Flow cytometric analyses showed that PF543 treatment significantly induced tumor-infiltrating CD4+ T cells and CD8+ T cells in the TME (Fig. 2f–i and Supplementary Fig. 2a–c). This evidence concerns the gene CD8A and neoplasm.